AsianScientist (Nov. 19, 2012) – Life sciences manufacturer Promega Corporation officially opened a new facility for its China operations in Shanghai last week.
The new site for Shanghai Promega Biological Products, Ltd. replaces an existing molecular biology reagent production site and provides additional research, development, and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market.
Since its purchase in June of this year, the building has been equipped for the manufacture of molecular biology and molecular diagnostic reagents. Under the leadership of General Manager Tom Duan, a team of 40 scientists, technicians and administrators will begin operations in the new facility in the next few weeks.
“China is an integral part of Promega’s manufacturing and business operations. In 1985, Promega and two Chinese partners established Sino-American Biotechnology Corporation (SABC), the first China-US biotech joint venture in China,” said Promega CEO Bill Linton.
“This recent investment in the new Shanghai cGMP manufacturing facility represents Promega’s continued commitment to life science in China.”
The new facility, called the Shanghai Promega Life Science Center, is one of five Promega manufacturing sites worldwide. Together these facilities manufacture biological and chemical reagents and instruments used in both life science research and molecular diagnostics. Promega products are manufactured under certified quality systems that meet the requirement of ISO 9001 or ISO 13485, depending on product intended use.
——
Source: Promega Corporation.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
